Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Aymes Shake powder 57g sachets banana
0913011C0BBAAAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 13,517 |
|
Aymes Shake powder 57g sachets strawberry
0913011C0BBAFAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 10,577 |
|
Aymes Shake powder 57g sachets vanilla
0913011C0BBAGAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 7,651 |
|
Aymes Shake powder 57g sachets chocolate
0913011C0BBACAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 6,503 |
|
Aymes Shake powder 57g sachets neutral
0913011C0BBAEAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 3,294 |
|
Aymes Shake powder (5 flavours)
0913011C0BBAIAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 3,078 |
|
Aymes Shake Starter Pack powder
0913011C0BBAHAG
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 1,645 |
|
Aymes Shake powder 57g sachets ginger
0913011C0BBADAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | 1,593 |
|
Aymes Shake powder 57g sachets chicken
0913011C0BBABAH
|
Aymes powder 1.6 kcal/ml milkshake | Powder 1.6 kcal/ml milkshake (0913011) | Nutrition and Blood | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.